Clinical Study to Assess the Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea (Glimepiride) in Healthy Male Subjects: Single-blinded, Randomized, Crossover Study.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2010
At a glance
- Drugs Glimepiride; Lobeglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms CKD-501 DDI
- 09 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2010 New trial record